BioInnovatise

BioInnovatise accelerates scientific discovery by offering high-quality CDMO services for plasmid DNA and viral vector-based research. The company collaborates with researchers in government, academia, and industry to support innovation in cell and gene therapy, immunotherapy, and precision medicine.

Core Service Offerings:

• Plasmid DNA Services: Molecular cloning (14 days), mutagenesis (Kunkel, PCR site-directed, random, saturation, transposon; 7–14 days), plasmid preparation (midiprep 7 days, maxiprep 14 days, large-scale up to 1 gram), and plasmid library construction (21–28 days).
• Viral Vector Packaging: AAV, adenovirus, lentivirus, and retrovirus packaging at small (500 μl, 14–28 days) and large (1 ml, 14–28 days) scales.
• CRISPR-Cas9 Services: CRISPR vectors (14 days), sgRNA cloning (7–14 days), cassette production and donor vector construction (14 days), and CRISPR knock-in/knock-out (4 months).
• Primary Mouse Embryonic Fibroblasts: Available with 3-week turnaround.

The company emphasizes rapid turnaround times and serves researchers across multiple therapeutic areas and disciplines.